🔎 Trials Near Me

Pradžia › Glioma › Džordžija

Glioma klinikiniai tyrimai Džordžija

7 tyrimai dėl Glioma ieško dalyvių vietose Džordžija.

Miestai Džordžija

Oficialus tyrimo tekstas (anglų kalba)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Renkami dalyviai1/2 fazė
12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-10-01 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Piedmont Oncology Research, Atlanta
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
Renkami dalyviai1/2 fazė
Iki 25 metų · Visoms lytims · Atnaujinta 2026-09-25 · NCT04094610

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Emory University/Children's Healthcare of Atlanta, Atlanta
Renkami dalyviai2 fazė
12 Months – 39 Years · Visoms lytims · Atnaujinta 2026-09-21 · NCT06838676

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Emory University, Atlanta
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT05303519

Atovaquone Combined With Radiation in Children With Malignant Brain Tumors

  • Arthur M Blank Hospital, Atlanta
  • Children's Healthcare of Atlanta: Scottish Rite, Atlanta
Renkami dalyviai1 fazė
Amžius nuo 2 iki 25 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06624371

Tumor Treating Fields for the Treatment of Brainstem Gliomas

  • Emory Proton Therapy Center, Atlanta
  • Emory University/Winship Cancer Institute, Atlanta
  • Emory Saint Joseph's Hospital, Atlanta
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-09-26 · NCT05310448

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.